Anstee, Q. M. Et Al. 2023. Tropifexor plus cenicriviroc combination versus monotherapy in non-alcoholic steatohepatitis: Results from the Phase 2b TANDEM study.. Hepatology (Baltimore, Md.) .

Anstee, Q. M., Lucas, K. J., Francque, S., Abdelmalek, M. F., Sanyal, A. J., Ratziu, V., ... Gadano, A. C.(2023). Tropifexor plus cenicriviroc combination versus monotherapy in non-alcoholic steatohepatitis: Results from the Phase 2b TANDEM study.. Hepatology (Baltimore, Md.) .

Anstee, Quentin Et Al. "Tropifexor plus cenicriviroc combination versus monotherapy in non-alcoholic steatohepatitis: Results from the Phase 2b TANDEM study.," Hepatology (Baltimore, Md.) , 2023

Anstee, Quentin M. Et Al. "Tropifexor plus cenicriviroc combination versus monotherapy in non-alcoholic steatohepatitis: Results from the Phase 2b TANDEM study.." Hepatology (Baltimore, Md.) , 2023

Anstee, Q. M. Et Al. (2023) . "Tropifexor plus cenicriviroc combination versus monotherapy in non-alcoholic steatohepatitis: Results from the Phase 2b TANDEM study.." Hepatology (Baltimore, Md.) .

@article{article, author={Quentin M Anstee Et Al. }, title={Tropifexor plus cenicriviroc combination versus monotherapy in non-alcoholic steatohepatitis: Results from the Phase 2b TANDEM study.}, journal={Hepatology (Baltimore, Md.)}, year=2023}